We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Psychiatry

Psychiatry

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Beyond Dopamine Blocking: Network Meta-Analysis Redefines Efficacy and Tolerability Hierarchies in Acute Schizophrenia
newsantipsychoticsNetwork meta-analysis

Beyond Dopamine Blocking: Network Meta-Analysis Redefines Efficacy and Tolerability Hierarchies in Acute Schizophrenia

By MedXY|Mar 6, 2026

A landmark network meta- **Developing Article Components** I’m now diving deep into the content, focusing on fleshing out each section. The Highlight section’s first drafts are complete. I’m incorporating the study’s

Evaluating Low-Dose Lithium Carbonate for the Management of Mild Cognitive Impairment: A 2-Year Randomized Pilot Study
NeurologyAlzheimer's diseaseclinical trial

Evaluating Low-Dose Lithium Carbonate for the Management of Mild Cognitive Impairment: A 2-Year Randomized Pilot Study

By MedXY|Mar 2, 2026

This pilot randomized clinical trial investigated low-dose lithium for Mild Cognitive Impairment (MCI). While primary outcomes regarding cognition and neuroimaging were not statistically significant, the study established the intervention&#

Mapping ADHD Heterogeneity: A New Frontier in Neurobiological Biotyping through Morphometric Similarity Networks
Clinical UpdatesADHDNeuroimaging

Mapping ADHD Heterogeneity: A New Frontier in Neurobiological Biotyping through Morphometric Similarity Networks

By MedXY|Mar 2, 2026

This review explores a groundbreaking study using normative modeling and morphometric similarity networks to identify three distinct neurobiological biotypes of ADHD, providing a framework for precision psychiatry.

Brief Psychological Intervention for Personality Disorder Shows No Benefit: Insights from the SPS Trial
newsclinical trialmental health

Brief Psychological Intervention for Personality Disorder Shows No Benefit: Insights from the SPS Trial

By MedXY|Mar 2, 2026

A multicentre RCT in England demonstrates that a 10-session brief psychological intervention offers no significant improvement in social functioning or cost-effectiveness for individuals with probable personality disorder, reinforcing the n

Digital Imagery-Competing Task Intervention Significantly Reduces Intrusive Memories in Trauma-Exposed Healthcare Staff: Evidence from the GAINS-02 Bayesian Trial
newsdigital healthhealthcare workers

Digital Imagery-Competing Task Intervention Significantly Reduces Intrusive Memories in Trauma-Exposed Healthcare Staff: Evidence from the GAINS-02 Bayesian Trial

By MedXY|Feb 25, 2026

A Bayesian adaptive randomized clinical trial reveals that a digital imagery-competing task intervention (ICTI) significantly reduces the frequency of intrusive memories and PTSD symptoms among healthcare workers exposed to pandemic-related

Enhanced Care, Regardless of Format, Reduces Postpartum Depression in High-Risk Populations: Insights from the EMBRACE Trial
newshealth equitymaternal health

Enhanced Care, Regardless of Format, Reduces Postpartum Depression in High-Risk Populations: Insights from the EMBRACE Trial

By MedXY|Feb 23, 2026

The EMBRACE randomized clinical trial demonstrates that both enhanced group and enhanced individual prenatal care significantly reduce postpartum depressive symptoms in low-income, diverse populations, suggesting that addressing social dete

Beyond Exercise Alone: The Synergistic Power of Combined High-Intensity Circuit Training and Sleep Health Interventions
newscardiometabolic healthHigh-Intensity Circuit Training

Beyond Exercise Alone: The Synergistic Power of Combined High-Intensity Circuit Training and Sleep Health Interventions

By MedXY|Feb 23, 2026

This randomized clinical trial demonstrates that combining high-intensity circuit training with targeted sleep health interventions significantly improves objective sleep quality and cardiometabolic markers in young women, outperforming eit

Beyond Monotherapy: Combined High-Intensity Circuit Training and Sleep Health Intervention Synergistically Enhances Sleep and Cardiometabolic Outcomes
newscardiometabolic healthCBT-I

Beyond Monotherapy: Combined High-Intensity Circuit Training and Sleep Health Intervention Synergistically Enhances Sleep and Cardiometabolic Outcomes

By MedXY|Feb 23, 2026

A randomized clinical trial demonstrates that combining high-intensity circuit training (HICT) with sleep health (SH) counseling significantly outperforms mono-interventions in improving sleep efficiency, reducing wakefulness, and enhancing

Synergistic Neuromodulation: Combined rTMS and tDCS Outperform Monotherapy in Patients with Anxious Depression
newsmajor depressive disorderneuromodulation

Synergistic Neuromodulation: Combined rTMS and tDCS Outperform Monotherapy in Patients with Anxious Depression

By MedXY|Feb 23, 2026

A double-blind RCT involving 240 patients reveals that combining rTMS and tDCS significantly improves remission rates and symptom reduction in Major Depressive Disorder with comorbid anxiety compared to single-modality or sham treatments, p

Injectable vs. Sublingual Buprenorphine: Shaping the Future of Emergency OUD Care
Emergency Medicinebuprenorphineclinical trial

Injectable vs. Sublingual Buprenorphine: Shaping the Future of Emergency OUD Care

By MedXY|Feb 22, 2026

The ED INNOVATION trial reveals that 7-day extended-release injectable buprenorphine is safe and as effective as sublingual formulations for treatment engagement, offering significant benefits in craving reduction and patient satisfaction e

Rest-Activity Rhythms as Digital Biomarkers: Predicting Relapse in Major Depressive Disorder via Actigraphy
newsactigraphycircadian rhythms

Rest-Activity Rhythms as Digital Biomarkers: Predicting Relapse in Major Depressive Disorder via Actigraphy

By MedXY|Feb 21, 2026

A landmark one-year actigraphy study reveals that sleep phase variability and daily activity amplitude are significant objective markers for predicting MDD relapse, offering a scalable path toward personalized, preventive psychiatric care.

Rapid-Acting Neuroplastogen TSND-201 Shows Significant Efficacy in PTSD: Results from the Phase 2 IMPACT-1 Trial
newsPsychopharmacologyPTSD

Rapid-Acting Neuroplastogen TSND-201 Shows Significant Efficacy in PTSD: Results from the Phase 2 IMPACT-1 Trial

By MedXY|Feb 20, 2026

A Phase 2 randomized clinical trial demonstrates that TSND-201, a novel neuroplastogen, significantly reduces PTSD symptoms and functional disability without intensive psychotherapy, offering a potentially rapid and durable treatment option

Universal School-Based Mindfulness Fails to Outperform Standard Care for Adolescent Mental Health: Insights from the MYRIAD Trial
newsAdolescent Depressionmachine learning

Universal School-Based Mindfulness Fails to Outperform Standard Care for Adolescent Mental Health: Insights from the MYRIAD Trial

By MedXY|Feb 19, 2026

A large-scale analysis of the MYRIAD trial indicates that universal school-based mindfulness training does not superiorly reduce depression risk in adolescents. While machine learning identified certain potential responders, the clinical be

Spirituality as a Protective Factor Against Substance Use Disorders: Evidence from a 21st-Century Meta-Analysis
newspsychiatrypublic health

Spirituality as a Protective Factor Against Substance Use Disorders: Evidence from a 21st-Century Meta-Analysis

By MedXY|Feb 19, 2026

A comprehensive meta-analysis of longitudinal studies involving over 540,000 participants reveals that spirituality and religious involvement are associated with a 13-18% reduction in harmful alcohol and drug use, offering significant impli

Neurofilament Light Chain: A High-Performance Biomarker for Differentiating bvFTD from Primary Psychiatric Disorders
Neurologybiomarkersfrontotemporal dementia

Neurofilament Light Chain: A High-Performance Biomarker for Differentiating bvFTD from Primary Psychiatric Disorders

By MedXY|Feb 14, 2026

This systematic review confirms that Neurofilament Light Chain (NfL) in blood and CSF effectively distinguishes behavioral variant frontotemporal dementia from psychiatric disorders, offering a powerful tool for early and accurate diagnosis

Polygenic Risk Scores Reveal the Complex Interplay Between Genetic Liability, Aggression, and Childhood Trauma in Suicidal Behavior
newspolygenic risk scorepsychiatry

Polygenic Risk Scores Reveal the Complex Interplay Between Genetic Liability, Aggression, and Childhood Trauma in Suicidal Behavior

By MedXY|Feb 14, 2026

This large-scale case-control study examines how polygenic risk scores for suicide attempt intersect with clinical traits and environmental stressors. Findings indicate that genetic liability significantly correlates with aggression, depres

Genetic Liability for Suicide Attempt Is Linked to Aggression and Environmental Stressors: New Insights into Polygenic Risk
newspolygenic riskpsychiatry

Genetic Liability for Suicide Attempt Is Linked to Aggression and Environmental Stressors: New Insights into Polygenic Risk

By MedXY|Feb 12, 2026

A landmark case-control study identifies significant associations between polygenic risk scores for suicide attempts and specific clinical traits, including aggression and depression severity, while also highlighting the interplay between g

Preparation Is Key: Study Finds Pre-Dose Therapy Hours Predict Success in Psychedelic-Assisted Therapy for Depression
newsdepressionpsychiatry

Preparation Is Key: Study Finds Pre-Dose Therapy Hours Predict Success in Psychedelic-Assisted Therapy for Depression

By MedXY|Feb 12, 2026

A systematic review and meta-analysis of 12 clinical trials reveals that the quantity of preparation therapy—not post-dose integration—significantly predicts depressive symptom reduction in psychedelic-assisted therapy, highlighting the cri

Childhood ADHD Traits Linked to Increased Risk of Physical Multimorbidity and Disability in Midlife
newsADHDchronic disease

Childhood ADHD Traits Linked to Increased Risk of Physical Multimorbidity and Disability in Midlife

By MedXY|Feb 12, 2026

A 46-year longitudinal study reveals that childhood ADHD traits significantly predict higher rates of physical health conditions, multimorbidity, and disability by middle age, mediated by modifiable risk factors like smoking, BMI, and psych

Youth with Histories of Out-of-Home Placement Face Significantly Longer Emergency Department Stays and Higher Restraint Rates During Mental Health Crises
Emergency Medicineemergency medicineOut-of-Home Placement

Youth with Histories of Out-of-Home Placement Face Significantly Longer Emergency Department Stays and Higher Restraint Rates During Mental Health Crises

By MedXY|Feb 12, 2026

A retrospective study at Mayo Clinic reveals that children with a history of out-of-home placement experience 24% longer ED stays and double the odds of physical or pharmacological restraint during psychiatric emergencies compared to their

Prev
6 / 19
1…45678…19
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles